Fibro appointed Kathleen Rubins as a Class III director, effective July 8, 2026, following the July 2, 2026 resignation of director Matt Link.
| IndividualMatt LinkKathleen Rubins, Ph.D. | RoleDirectorClass III Director; member, Audit Committee; Compensation Committee; Governance and Nominating Committee | Type of ChangeResignedAppointed | Effective DateJuly 2, 2026July 8, 2026 | ReasonNot disclosedNot disclosed | Replacement InfoKathleen Rubins appointed to BoardWill serve until the 2029 annual meeting of stockholders | Background DetailsNot disclosedFounding Director, Trivedi Institute for Space and Global Biomedicine; Professor of Computational and Systems Biology, Univ. of Pittsburgh School of Medicine; US Army Reserve Innovation Officer (Major/O-4); former NASA astronaut (Aug 2009–July 2025); Ph.D. Stanford; B.S. UCSD | Board/Committee Role ChangesNot disclosedAppointed to Audit, Compensation, and Governance and Nominating Committees |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.